This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.
Company Profile:
SinoMab BioScience Ltd
Market Cap (USD):
$313.0 M
Country:
Hong Kong
Sector:
HK Healthcare
Industry:
HK Biotechnology
Company Profile:
Olema Pharmaceuticals, Inc.
Market Cap (USD):
$312.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Rocket Pharmaceuticals, Inc.
Market Cap (USD):
$312.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Nektar Therapeutics
Market Cap (USD):
$307.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Corvus Pharmaceuticals, Inc.
Market Cap (USD):
$304.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Taiwan Liposome Company, Ltd.
Market Cap (USD):
$302.9 M
(Sept. 1, 2021)
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Abeona Therapeutics Inc.
Market Cap (USD):
$301.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Oyster Point Pharma, Inc.
Market Cap (USD):
$299.9 M
(Dec. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Healios K.K.
Market Cap (USD):
$299.3 M
Country:
Japan
Sector:
Japanese Healthcare
Industry:
Japanese Biotechnology
Company Profile:
OBI Pharma, Inc.
Market Cap (USD):
$298.6 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
DBV Technologies SA
Market Cap (USD):
$298.4 M
Country:
France
Sector:
French Healthcare
Industry:
French Biotechnology
Company Profile:
Cerus Corporation
Market Cap (USD):
$294.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Vanda Pharmaceuticals Inc.
Market Cap (USD):
$292.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
CHO Pharma, Inc.
Market Cap (USD):
$292.3 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Foghorn Therapeutics Inc.
Market Cap (USD):
$286.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Cerecor Inc.
Market Cap (USD):
$285.0 M
(June 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
ADC Therapeutics SA
Market Cap (USD):
$282.8 M
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Biotechnology
Company Profile:
Gossamer Bio, Inc.
Market Cap (USD):
$281.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Ocugen, Inc.
Market Cap (USD):
$279.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Frontage Holdings Corp
Market Cap (USD):
$278.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Mycenax Biotech, Inc.
Market Cap (USD):
$270.7 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Immutep Limited
Market Cap (USD):
$266.4 M
(July 1, 2024)
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
Imugene Limited
Market Cap (USD):
$264.1 M
(July 1, 2024)
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
Verastem, Inc.
Market Cap (USD):
$263.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Mabpharm Ltd
Market Cap (USD):
$262.7 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Allogene Therapeutics, Inc.
Market Cap (USD):
$260.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Inozyme Pharma, Inc.
Market Cap (USD):
$258.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aldeyra Therapeutics, Inc.
Market Cap (USD):
$257.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Chiasma, Inc.
Market Cap (USD):
$253.0 M
(July 1, 2021)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Xspray Pharma AB
Market Cap (USD):
$252.9 M
(July 1, 2024)
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Biotechnology